We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
-8.7%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$203M
AUM Growth
-$24.7M
Cap. Flow
+$4.89M
Cap. Flow %
2.42%
Top 10 Hldgs %
43.06%
Holding
208
New
6
Increased
82
Reduced
72
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 23.16%
2 Technology 21.99%
3 Communication Services 8.08%
4 Financials 7.58%
5 Consumer Discretionary 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETJ
176
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$561M
$147K 0.07%
19,174
-220
-1% -$1.77K
TGTX icon
177
TG Therapeutics
TGTX
$8.4B
$130K 0.06%
+15,500
New +$216K
FLG
178
Flagstar Bank National Association
FLG
$6.21B
$113K 0.06%
3,333
-500
-13% -$18.1K
AUTL
179
Autolus Therapeutics
AUTL
$383M
$110K 0.05%
47,000
STXS icon
180
Stereotaxis
STXS
$154M
$109K 0.05%
69,060
+9,500
+16% +$15.2K
VVR icon
181
Invesco Senior Income Trust
VVR
$456M
$105K 0.05%
26,755
+7,050
+36% +$27.4K
BFX
182
DELISTED
BowFlex Inc.
BFX
$103K 0.05%
121,500
+45,092
+59% +$44.5K
HA
183
DELISTED
Hawaiian Holdings, Inc.
HA
$95K 0.05%
15,000
+1,500
+11% +$14.2K
ONDS icon
184
Ondas Inc
ONDS
$3.72B
$92.6K 0.05%
152,000
+42,100
+38% +$46.4K
IBRX icon
185
ImmunityBio
IBRX
$8.04B
$90.4K 0.04%
53,500
-17,500
-25% -$35.1K
ICCC icon
186
ImmuCell
ICCC
$101M
$83.4K 0.04%
15,617
-500
-3% -$2.54K
HYFM icon
187
Hydrofarm Holdings
HYFM
$3.25M
$80.5K 0.04%
6,600
+510
+8% +$5.69K
BCS icon
188
Barclays
BCS
$93.8B
$77.9K 0.04%
10,000
LPCN icon
189
Lipocine
LPCN
$18.4M
$55.9K 0.03%
18,761
-10,512
-36% -$44.2K
AKBA icon
190
Akebia Therapeutics
AKBA
$359M
$33.6K 0.02%
29,500
+11,184
+61% +$14.4K
CATX icon
191
Perspective Therapeutics
CATX
$341M
$30.1K 0.01%
11,000
TVRD
192
Tvardi Therapeutics
TVRD
$30M
$23.5K 0.01%
+389
New +$36.5K
BYRN icon
193
Byrna Technologies
BYRN
$75.8M
$22.4K 0.01%
10,000
HYZN
194
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$18.8K 0.01%
300
AMLI
195
DELISTED
American Lithium Corp. Common Stock
AMLI
$14.3K 0.01%
10,000
AMRN
196
Amarin Corp
AMRN
$292M
$11.6K 0.01%
+630
New +$13.7K
PVLA
197
Palvella Therapeutics
PVLA
$2.26B
$3.49K ﹤0.01%
146
-63
-30% -$1.35K
BTU icon
198
Peabody Energy
BTU
$2.73B
-13,559
Closed -$294K
CI icon
199
Cigna
CI
$74.5B
-717
Closed -$201K
FXH icon
200
First Trust Health Care AlphaDEX Fund
FXH
$994M
-2,189
Closed -$237K

Similar funds

Wealth Effects's Q3 2023 Portfolio in Review

As of Q3 2023, Wealth Effects held 208 positions worth $203M, down 11% from $227M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Wealth Effects's Q3 2023 filing shows 6 new, 82 increased, 72 reduced and 11 closed positions. Its largest new stake was Novo Nordisk: 5,581 shares worth $508K. The largest sale was Apple, an estimated $491K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

  • Wealth Effects's largest Q3 2023 buy was Novo Nordisk: 5,581 shares worth $508K.
  • Wealth Effects added most to Meta Platforms (Facebook) in Q3 2023, an estimated $3.51M increase.
  • Wealth Effects's biggest Q3 2023 reduction was Apple, cutting an estimated $491K.
  • Wealth Effects fully exited Peabody Energy in Q3 2023, selling an estimated $294K.
  • Wealth Effects's ten largest holdings make up 43% of its $203M portfolio in Q3 2023.
  • Wealth Effects opened 6 new positions and closed 11 in Q3 2023.
  • Wealth Effects's portfolio value fell 11% quarter-over-quarter to $203M.

Based on Wealth Effects's 13F filing for Q3 2023, filed 16 Oct 2023.